Write to members of Indian governement and European Commission to save affordable medicines and access to life-saving treatments in Africa, Asia and Latin America !
Positive Living HIV (PLHIV) organisations in Malaysia yesterday expressed concern over the potential negative impact on HIV medication of Free Trade Agreements (FTAs) which the government is currently negotiating with the United States and the European Commission (EC).
The Korea-EU FTA must be dismantled. And the lives of patients in over 120 countries are on the line regarding the India-EU FTA. What will devastate the Pharmacy of the World must also be stopped.
People in Asia living with HIV and who depend on affordable generic AIDS medicines to stay alive have impressed upon the Indian government to stand strong against European Union demands on the sensitive Intellectual Property (IP) chapter in ongoing Free Trade Agreement (FTA) negotiations.
Thousands of people with HIV and cancer marched through the streets of India’s capital Wednesday to protest a planned trade deal with the European Union that they claim would restrict access to affordable medicines.
The EU’s proposed trade agreement is riddled with intellectual property provisions that would harm India’s 2005 Patent Act and block public-interest rulings such as the Aluvia decision.
"It’s like an ant fighting an elephant. We are one of the weakest and poorest groups and they (the EU and the pharmaceutical industry) are among the richest and strongest."
Public Citizen and Forum on Democracy and Trade met with US Trade Representative staff on January 3 to be briefed on the Obama administration’s negotiation of the TPP with respect to the planned IP chapter and the rumored chapter on pharmaceutical reimbursement programs.
Kenyan activists have written to the European Union and the Kenya Government, protesting what they term damaging trade agreements such as the European Union-India Free Trade Agreement and the Anti-Counterfeiting Trade Agreement. They say the pacts would damage the fight against Aids.
L’industrie du médicament générique et les régimes d’assurance médicaments pourraient souffrir d’un accord de libre-échange entre le Canada et l’Union européenne, selon une étude commandée par l’Association canadienne du médicament générique rendue publique lundi 7 février.
Despite all official assurances, the path towards a free trade agreement between India and the European Union this year remains ambiguous, as both sides are unwilling to relax their stand on the biggest stumbling block — the issue of “data exclusivity”.
Of particular concern is that proposed TPPA multilateral
investor–state dispute settlement procedures would allow
US corporations (as well as those of other TPPA nations) to
obtain damages against Australian governments through
international arbitral proceedings if their investments are
impeded by Australian public health and environment
protection legislation.
The main focus of this comprehensive policy guide—the first of its kind solely dedicated to the region—is to analyze the effect of bilateral trade agreements on public health regimes and access to medicines in the countries of the Eastern Mediterranean Region.
El TLC entre la UE e India pondrá en peligro la vida de millones de personas que dependen de los medicamentos genéricos producidos en el subcontinente.
Drug patent restrictions by the United States and the European Union in trade negotiations with emerging countries will harm the Thai pharmaceutical industry and affect local patients, say researchers.
Marking strong protest against the proposed signing of the European Union-India Free Trade Agreement on IP Provision, a mass protest rally was taken out today jointly by the Centre for Social Development in collaboration with organisation working on drugs and HIV/AIDS, North East Diaglogue Forum, Women Action for Development and Bosco Mangal, Chingmeirong Don Bosco Society, Imphal.
A confidential Trans-Pacific Partnership Agreement negotiating paper authored by New Zealand suggests that the trade pact’s patent and copyright provisions be no more stringent than existing global standards
Fears have been raised that cheap life-saving anti-retroviral drugs may no longer be available in Kenya if a trade agreement between the EU and India is concluded.
The government is coming under increasing attack from activists for pushing ahead with EU-Thailand free trade agreement talks which include alcohol, tobacco and medicines.
DNP+ and MSF Access Campaign India have set up a blog about the ongoing negotiations of a number of multi- and bilateral free trade agreements, which harm the access to essential medicines.
HAI (Health Action International) Europe and HAI Latin America have formed an alliance to monitor and lobby negotiations on Association Agreements between the EU and the countries of the Andean region on Intellectual Property Rights demanded by the EU which are likely to have a negative effect on Access to Essential Medicines.
A submission to the Australian Senate Select Committee on the US-Australia Free Trade Agreement by Prof Peter Drahos, Dr Thomas Faunce, Martyn Goddard and
Prof David Henry (May 2004)